Clinical Trial Update: Serum GFAP, NfL, VEGF and Clinical Progression in Progressive MS

View source ↗

Summary

This clinical trial update from Ondokuz Mayıs University investigates serum biomarkers GFAP, NfL, and VEGF and their relation to clinical progression in progres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Snippet

Sponsor: Ondokuz Mayıs University | Conditions: Multiple Sclerosis | Status: NOT_YET_RECRUITING